New FDA guidance documents

被引:0
|
作者
Bradshaw, Sheldon T. [1 ]
机构
[1] US FDA, Rockville, MD 20857 USA
关键词
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
引用
收藏
页码:429 / 431
页数:3
相关论文
共 50 条
  • [31] RECOMMENDATIONS FOR THE USE OF PATIENT REPORTED OUTCOMES TO ASSESS TREATMENT EFFICACY IN CLINICAL GUIDANCE DOCUMENTS RELEASED BY THE FDA AND EMEA
    Arbuckle, R.
    Marquis, P.
    Caron, M.
    Emery, M. P.
    Scott, J.
    VALUE IN HEALTH, 2009, 12 (07) : A253 - A253
  • [32] Pulse Oximetry and Skin Pigmentation-New Guidance From the FDA
    Lipnick, Michael S.
    Ehie, Odinakachukwu
    Igaga, Elizabeth N.
    Bicker, Philip
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,
  • [33] FDA issues pharmacogenomics guidance
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (03) : 177 - 177
  • [34] FDA Documents Achievements and Plans for Future
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2021, 34 (03) : 8 - 9
  • [35] Fda documents achievements and plans for future
    Wechsler, Jill
    Pharmaceutical Technology, 2021, 45 (03) : 14 - 16
  • [36] Improving Access to FDA Reviews and Documents
    Mathis, Lisa L.
    Pica-Branco, Denise
    Tassinari, Melissa S.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (20): : 2204 - 2205
  • [37] New Decade, New FDA Guidance for Diabetes Drug Development Lessons Learned and Future Directions
    Ferro, Enrico G.
    Michos, Erin D.
    Bhatt, Deepak L.
    Lincoff, A. Michael
    Elshazly, Mohamed B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (21) : 2522 - 2526
  • [39] “Assessment of Pressor Effects of Drugs”—A New US FDA Draft Guidance for Industry
    J. Rick Turner
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 397 - 399
  • [40] FDA guidance on pharmacogenomics data submission
    Savage, DR
    NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (12) : 937 - 938